quinoxalines has been researched along with xylazine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cavero, I; Doxey, JC; Roach, AG; Strachan, DA | 1 |
Choi, AM; Chung, HS; Fessler, HE; Otterbein, L | 1 |
Álvarez de La Rosa, D; Arce-Franco, M; Armas-González, E; Barreiro, O; Díaz-González, F; Domínguez-Luis, MJ; Feria, M; Herrera-García, AM; Machado, JD; Pec, MK; Sánchez-Madrid, F | 1 |
3 other study(ies) available for quinoxalines and xylazine
Article | Year |
---|---|
Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain; Brimonidine Tartrate; Chickens; Clonidine; Guanabenz; Guanfacine; Guanidines; Imidazoles; Phenylacetates; Quinoxalines; Receptors, Adrenergic, alpha; Sleep; Thiophenes; Time Factors; Xylazine | 1983 |
Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Creatinine; Escherichia coli; Hemodynamics; Lipopolysaccharides; Lung; Male; Peroxidase; Quinoxalines; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha; Xylazine; Yohimbine | 1996 |
Prevention of neutrophil extravasation by α2-adrenoceptor-mediated endothelial stabilization.
Topics: Adherens Junctions; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antigens, CD; beta Catenin; Brimonidine Tartrate; Cadherins; CD11b Antigen; Endothelium, Vascular; gamma Catenin; Humans; Idazoxan; Inflammation; Intercellular Adhesion Molecule-1; L-Selectin; Male; Mice; Neutrophils; Peritonitis; Quinoxalines; Receptors, Adrenergic, alpha-2; Thioglycolates; Transendothelial and Transepithelial Migration; Tumor Necrosis Factor-alpha; Up-Regulation; Xylazine; Zymosan | 2014 |